Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

NCT00288236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Rimonabant (SR141716)
DRUG: Placebo

Sponsor

Sanofi